| 2026-08-21 | Press release | RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement |
| 2026-08-21 | Press release | A Grandfather Struggled with Treatment for Late-Stage Pancreatic Cancer — Until a Clinical Trial Helped Him Beat the Odd |
| 2026-08-21 | Press release | Could a New Approach to Chemotherapy Change the Future of Pancreatic Cancer? |
| 2026-08-21 | Press release | The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to an experimental delivery method for t |
| 2026-08-21 | Press release | New Cancer Tech Sends Chemo Straight To Tumors |
| 2026-08-21 | Press release | Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer |
| 2026-08-21 | Press release | Trans-Arterial Micro-Perfusion Could Boost Systemic Chemotherapy Efficacy in Unresectable Pancreatic Cancer: With Gregor |
| 2026-08-21 | Press release | Delivering Chemotherapy Directly to the Tumor: Inside TAMP Technology |
| 2026-08-21 | Press release | New Device Delivers Targeted Chemo for Pancreatic Cancer, Offering Fresh Hope |
| 2026-08-21 | Press release | Moffitt Using New Approach to Treat Pancreatic Cancer |
| 2026-08-20 | Press release | RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for |
| 2026-08-12 | Press release | RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quart |
| 2026-08-11 | Press release | RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Canc |
| 2026-08-06 | Press release | RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targe |
| 2026-07-29 | Press release | RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p. |
| 2026-06-11 | Press release | RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanc |
| 2026-06-04 | Press release | RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June |
| 2026-05-28 | Press release | RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer |
| Press release | RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th |
| Press release | RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter |
| Press release | RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET |
| Press release | RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update |
| Press release | RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30 |
| Press release | RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 |
| Press release | RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9t |
| Press release | RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on |
| Press release | RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Pro |
| Press release | RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum |
| Press release | RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p |
| Press release | RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16t |
| Press release | RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p. |
| Press release | RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st |
| Press release | RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th |
| Press release | RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET |
| Press release | RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET |
| Press release | RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights |
| Press release | RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 i |
| Press release | RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024 |
| Press release | RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024 |
| Press release | RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024 |